288 related articles for article (PubMed ID: 21688390)
1. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
[TBL] [Abstract][Full Text] [Related]
2. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging.
Zhang Y; Zhang Y; Yin L; Xia X; Hu F; Liu Q; Qin C; Lan X
Contrast Media Mol Imaging; 2017; 2017():6081724. PubMed ID: 29434531
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
Arosio D; Manzoni L; Araldi EM; Scolastico C
Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
[TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
6. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
[TBL] [Abstract][Full Text] [Related]
7. Multiphoton-absorption-induced-luminescence (MAIL) imaging of tumor-targeted gold nanoparticles.
Dowling MB; Li L; Park J; Kumi G; Nan A; Ghandehari H; Fourkas JT; DeShong P
Bioconjug Chem; 2010 Nov; 21(11):1968-77. PubMed ID: 20964333
[TBL] [Abstract][Full Text] [Related]
8. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors.
Xiong L; Chen Z; Tian Q; Cao T; Xu C; Li F
Anal Chem; 2009 Nov; 81(21):8687-94. PubMed ID: 19817386
[TBL] [Abstract][Full Text] [Related]
9. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
10. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
11. Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging.
Yang Y; Zhang L; Cai J; Li X; Cheng D; Su H; Zhang J; Liu S; Shi H; Zhang Y; Zhang C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1718-32. PubMed ID: 26731347
[TBL] [Abstract][Full Text] [Related]
12. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging.
Zako T; Nagata H; Terada N; Utsumi A; Sakono M; Yohda M; Ueda H; Soga K; Maeda M
Biochem Biophys Res Commun; 2009 Mar; 381(1):54-8. PubMed ID: 19351594
[TBL] [Abstract][Full Text] [Related]
14. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice.
Vilchis-Juárez A; Ferro-Flores G; Santos-Cuevas C; Morales-Avila E; Ocampo-García B; Díaz-Nieto L; Luna-Gutiérrez M; Jiménez-Mancilla N; Pedraza-López M; Gómez-Oliván L
J Biomed Nanotechnol; 2014 Mar; 10(3):393-404. PubMed ID: 24730235
[TBL] [Abstract][Full Text] [Related]
17. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
[TBL] [Abstract][Full Text] [Related]
18. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
19. Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.
Adulnirath A; Chung SW; Park J; Hwang SR; Kim JY; Yang VC; Kim SY; Moon HT; Byun Y
J Control Release; 2012 Nov; 164(1):8-16. PubMed ID: 23063549
[TBL] [Abstract][Full Text] [Related]
20. A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins.
Ko HY; Choi KJ; Lee CH; Kim S
Biomaterials; 2011 Feb; 32(4):1130-8. PubMed ID: 21071077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
